Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 323 M308 M317 M318 M305 M 1.25 B Research & development ————— — Operating income 257 M283 M230 M263 M279 M 1.05 B Non-Operating Income, Total 3 M-2 M4 M8 M20 M 30 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 00000 0 Unusual income/expense 3 M-2 M4 M8 M20 M 30 M Pretax income 216 M233 M187 M226 M251 M 897 M Equity in earnings ————— — Taxes -55 M58 M-13 M21 M53 M 119 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 271 M175 M200 M205 M198 M 778 M Discontinued operations ————— — Net income 271 M175 M200 M205 M198 M 778 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 271 M175 M200 M205 M198 M 778 M Basic earnings per share (Basic EPS) 2.171.421.641.691.63 6.38 Diluted earnings per share (Diluted EPS) 2.161.421.631.691.63 6.37 Average basic shares outstanding 124.11 M122.66 M121.09 M122.07 M119.97 M — Diluted shares outstanding 124.48 M122.88 M121.35 M122.38 M120.19 M — EBITDA 297 M324 M270 M305 M324 M 1.22 B EBIT 257 M283 M230 M263 M279 M 1.05 B Cost of revenue 1.42 B1.34 B1.26 B1.28 B1.34 B 5.22 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 40 M41 M40 M42 M45 M 168 M